These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3314004)

  • 1. Impaired fractional excretion of lithium: a very early marker of cyclosporine nephrotoxicity.
    Vincent HH; Wenting GJ; Schalekamp MA; Jeekel J; Weimar W
    Transplant Proc; 1987 Oct; 19(5):4147-8. PubMed ID: 3314004
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of lithium clearance measurements to assess renal tubular function in experimental and clinical cyclosporine nephrotoxicity.
    Whiting PH; Propper DJ; Simpson JG; McKay J; Jones MC; Catto GR
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):675-80. PubMed ID: 3388506
    [No Abstract]   [Full Text] [Related]  

  • 3. Impaired fractional excretion of lithium: an early marker of cyclosporine-induced changes in renal hemodynamics.
    Vincent HH; Wenting GJ; Versluis DJ; Weimar W; Schalekamp MA
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):681-5. PubMed ID: 3291303
    [No Abstract]   [Full Text] [Related]  

  • 4. Usefulness of fractional excretion of sodium as index of cyclosporine nephrotoxicity in renal transplantation.
    Morales JM; Andres A; Alcazar JM; Prieto C; Diaz de Tueste I; Ruilope LM; Rodicio JL
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):691-9. PubMed ID: 3291305
    [No Abstract]   [Full Text] [Related]  

  • 5. Fractional excretion of sodium represents an index of cyclosporine nephrotoxicity in the early post-transplant period.
    Morales JM; Andres A; Prieto C; Ruilope LM; Alcazar JM; Oliet A; Praga M; Rodicio JL
    Transplant Proc; 1987 Oct; 19(5):4005-7. PubMed ID: 3313985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathology of cyclosporine.
    Wallace AC
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):117-22. PubMed ID: 3895653
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine nephrotoxicity.
    Mihatsch MJ; Thiel G; Ryffel B
    Adv Nephrol Necker Hosp; 1988; 17():303-20. PubMed ID: 3124545
    [No Abstract]   [Full Text] [Related]  

  • 8. Is cyclosporine-associated nephrotoxicity progressive?
    Vanrenterghem Y; Waer M; Roels L; Lerut T; Michielsen P
    Transplant Proc; 1987 Oct; 19(5):4031-2. PubMed ID: 3313992
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence against chronic progressive cyclosporine nephrotoxicity.
    Ben-Maimon CS; Burke JF; Besarab A; Jarrell BE; Francos GC; Moyer SS
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1260-2. PubMed ID: 1989206
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary cytologic abnormalities in bone marrow transplant recipients of cyclosporin.
    Stella F; Troccoli R; Stella C; Battistelli S; Biagioni S; Giardini C; Baronciani D; Manenti F
    Acta Cytol; 1987; 31(5):615-9. PubMed ID: 3314304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
    Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
    [No Abstract]   [Full Text] [Related]  

  • 12. Differentiation of cyclosporine A-induced nephrotoxicity from acute rejection in renal transplantation using fine-needle aspiration biopsies.
    Zannier A; Mutin M; Touraine JL; Traeger J
    Transplant Proc; 1987 Oct; 19(5):3630-2. PubMed ID: 3313874
    [No Abstract]   [Full Text] [Related]  

  • 13. Issues in the pathophysiology of nephrotoxic renal tubular cell injury pertinent to understanding cyclosporine nephrotoxicity.
    Weinberg JM
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):81-90. PubMed ID: 3895674
    [No Abstract]   [Full Text] [Related]  

  • 14. Five-year serial renal graft biopsy study in cyclosporine-treated patients.
    Wilczek H; Bohman SO; Klintmalm G; Groth CG
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):812-5. PubMed ID: 3291319
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine A-related proximal tubular dysfunction: impaired handling of uric acid.
    Versluis DJ; Wenting GJ; Jeekel J; Weimar W
    Transplant Proc; 1987 Oct; 19(5):4029-30. PubMed ID: 3313991
    [No Abstract]   [Full Text] [Related]  

  • 17. "Cyclosporine-A nephrotoxicity in renal allograft recipients".
    Nix K; Plawecki HM
    J Nephrol Nurs; 1985; 2(5):220-2. PubMed ID: 3903104
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nephrological aspects of lithium metabolism in the body].
    Rybakowski J
    Pol Tyg Lek; 1975 Dec; 30(52):2193-6. PubMed ID: 1105480
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine nephrotoxicity in orthotopic liver transplantation.
    Gonwa TA; Poplawski SC; Husberg BS; Nery JR; Klintmalm GB
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):401-4. PubMed ID: 3291276
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine nephrotoxicity: studies in laboratory animals.
    Sullivan BA; Hak LJ; Finn WF
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):145-54. PubMed ID: 3895655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.